Is Melatonin Safe for Kids? What the FDA and Poison Control Data Show

Is melatonin safe for kids? At the low, short-term doses pediatricians actually recommend, current guidance from the American Academy of Pediatrics and the American Academy of Sleep Medicine suggests yes, taken with a doctor’s input. The more urgent problem is different: many commercial gummies don’t contain the dose printed on the label, and unsupervised children are swallowing whole bottles at a rate that has overwhelmed poison control centers over the past decade.

Those are two separate questions people tend to collapse into one. Melatonin taken correctly, in a small dose, for a short stretch of time, has a reasonably good safety record in children. Melatonin sold in a mislabeled, candy-colored gummy and left within reach of a toddler is a different hazard, and it’s the one driving most of the recent news coverage.

What did the FDA warn about melatonin gummies?

The FDA hasn’t issued one sweeping consumer warning naming melatonin gummies as unsafe. What it has done is narrower and, in some ways, more useful. In a study published in Drug Testing and Analysis (posted online in October 2024), scientists in the FDA’s own Office of Regulatory Science at the Center for Food Safety and Applied Nutrition tested 110 melatonin products, about 70% of them either labeled for children or carrying general dosing instructions with no age restriction. They found melatonin in 108 of the 110 products, with actual content ranging from 0% to 667% of what the label claimed. One edible, printed with a dose of roughly half a milligram, delivered 3.3mg per serving, about six and a half times what the label promised — and dose accuracy varied widely enough across the rest of the sample that no single product’s result should be read as typical of the category.

Individual cases also surface on their own timeline. Dkiru LLC voluntarily recalled 13,920 bottles of its Adndale Magnesium Glycinate Gummies in May 2026 after testing turned up undeclared melatonin, a supplement never marketed as containing any, with no data on record about how much was actually inside; the FDA classified the recall the following month.

Is melatonin regulated as a drug or a supplement in the US?

As a supplement, not a drug. Under the 1994 Dietary Supplement Health and Education Act, melatonin is classified as a food product, which means manufacturers don’t have to prove it’s safe or effective at a given dose before putting it on a shelf, and no federal agency caps the serving size. The wide dose range in American pharmacies, the label inaccuracies the FDA’s own lab found, and the absence of a mandated child-resistant cap all trace back to this one regulatory classification. In the United Kingdom, melatonin is prescription-only at every dose; the European Union limits over-the-counter sales to a short list of approved indications, mainly jet lag. A shopper in the US can buy a 10mg or 20mg bottle from the same aisle where a shopper in Germany or the UK would first need to see a doctor.

How much has melatonin poisoning in children increased?

Sharply enough to change what shows up on a poison center’s own top-ten list. A 2022 CDC study led by researcher Karima Lelak and colleagues, published in Morbidity and Mortality Weekly Report, found that pediatric melatonin ingestion calls to US poison control centers rose 530% between 2012 and 2021, growing from 0.6% of all pediatric poisoning calls to 4.9% of them. Across that decade, poison centers logged 260,435 melatonin-related calls involving children, and by 2020 melatonin had become the single most commonly reported substance in pediatric poisoning calls nationwide, ahead of long-standing entries like cosmetics and household cleaners.

Most of those calls don’t end at a hospital. The same body of poison-center data shows that roughly 98% of children who accidentally swallow melatonin have only mild symptoms, usually drowsiness or stomach upset, or none at all. The remaining share is what’s driving a real, smaller rise in pediatric hospitalizations, concentrated heavily among children five and under who got into a bottle left on a counter or nightstand.

How much melatonin is too much for a child?

There’s no single toxic dose established for children, which is itself part of the problem; what exists instead is a therapeutic range that most commercial products blow past. The AAP and the AASM both recommend starting at 0.5mg to 1mg, taken 30 to 90 minutes before bedtime, and note that most children, including those with ADHD, don’t need more than 3mg to 6mg even at the high end of a course of treatment. A standard US children’s gummy commonly contains 5mg or 10mg per piece, so a child eating the “one gummy” serving printed on some labels is already past the upper end of pediatric guidance before touching a second one.

Neither professional body recommends melatonin as a routine, nightly fix. Both frame it as a short-term bridge, useful for resetting a schedule after travel or supporting a diagnosis like ADHD or autism, and both say it should follow a conversation with a pediatrician rather than a trip down the vitamin aisle. Shifting a child’s sleep timing without any supplement at all is a narrower project than it sounds; the mechanics behind gradually moving a kid’s wake-up time earlier before school starts work on the same underlying clock whether the goal is a September reset or recovery from a rough stretch of travel, and the evidence for which bedtime habits actually hold up covers most of the ground a bottle is being asked to fix.

What is actually changing about melatonin packaging and labeling?

Not a federal rule, at least not yet. In April 2024, the Council for Responsible Nutrition, the supplement industry’s own trade association, adopted voluntary guidelines calling for child-deterrent packaging on melatonin sold in flavored, chewable forms, plus label warnings about drowsiness, alcohol interactions, and choking risk on products aimed at children under four. Member companies were given up to 18 months to comply, and compliance is voluntary: a manufacturer that ignores the guidelines faces no fine, only the risk of bad publicity if a poisoning case draws attention.

For a supplement with this much label variance, the clinical research behind the low adult effective dose is still a useful anchor even outside the packaging debate: it’s the number pediatric guidance scales down from, and it’s a long way from what a typical US bottle actually contains. Until labeling accuracy and packaging catch up with that gap, the most reliable safeguard is the oldest one available: keep the bottle somewhere a small child can’t reach it, the same rule that applies to every other medicine in the house, regardless of what the label promises.